- Record: found
- Abstract: not found
- Article: not found
A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM) – results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
S. Popat, A Curioni-Fontecedro, V Polydoropoulou, R Shah, M. O'Brien, A Pope, M. O'BRIEN, M. O’BRIEN, R. SHAH
2019
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.